But the European Union is not waiting for USA emergency authorization to order the vaccine.
"This has freed the company from bureaucratic red tape during its phase 1-3 trials that could have slowed the process, and it also reduces the potential for future litigation against ownership issues and application of [intellectual property] developed from the vaccine", said Hiatt, who noted that Pfizer got a $1.95 billion deal with the US government under Operation Warp Speed to distribute 100 million doses and can negotiate a contract for another 500 million.
The announcement has injected a glimmer of hope into the hearts of people and fuel into the stock markets as well. This pain and side effects were more than the first dose. During the first phase, US health care workers, emergency responders and individuals at higher risk of severe illness would be eligible for vaccination. In Louisiana, officials are planning a remote exercise this week to play out different scenarios exploring how the process might unfold.
"I feel like physicians in the state of MS and across the country will be unified once we've looked at the data ourselves", he says. Frank Welch, director of Louisiana's immunization program. The issue is getting people to take it and that's something that everybody is concentrating on. But pharmacies and other providers that do not always collect that information objected.
Covid-19 vaccine: The scientist behind Pfizer and Biontech's successful Kovid-19 vaccine claims that it will end the epidemic. The effectiveness of a vaccine can only be firmly determined once millions of people get it.
That said, antibodies are probably not the whole answer to the body's response to this (and indeed other) coronaviruses. However, the country, and the world, still have a way to go before coronavirus vaccines become available to ordinary Americans.
Once a concrete vaccine enters the market, it will change the global trajectory against the pandemic.
In May, Canada's National Research Council (NRC) said it would collaborate with CanSino Biologics, a Chinese company with longstanding ties to Canada developing a vaccine based in part on Canadian research.
The news from Moderna also comes on the heels of Dr. Anthony Fauci, the country's lead public health expert, saying he anticipates data from a second COVID-19 vaccine could come quickly, The Financial Times reported. "Help is on the way, but it isn't here yet".
US COVID-19 cases surpass 10 mn: Johns Hopkins University
Government data also showed that the number of people reported to have tested positive for COVID-19 has increased by 20,572. The United States reported the most cases and deaths around the world, which stood at 9,879,323 and 237,192, respectively.
Nurse administers a vaccine, not during the Pfizer trial.
"There has been a lot of preparatory work going on since March", she said.
Moderna Inc is close to releasing efficacy results for its similar vaccine, which requires an easier to accommodate storage temperature of minus 20 degrees Celsius (minus 4°F).
It also marks widespread wariness of the advice from the CDC, which on August 26 urged healthcare providers not to purchase ultra low temperature (ULT) freezers, saying it was working on solutions for Pfizer's "very complex storage and handling requirements".
The containment structures for the vaccine would be professional and expensive freezers.
"Once this vaccine is available to the population, it is absolutely critical that we get to between 55% and 60% of the people vaccinated", Carlos Blanco, CEO of the Lynn Institute, said in an interview on Wednesday.
"If we only have the Pfizer vaccine and everyone needs two doses, clearly that's a hard ethical dilemma", Trudie Lang, director of The Global Health Network at the University of Oxford's Nuffield Department of Medicine, told AFP.
"The logistics of transporting and storing this will pose a huge challenge and will take time".